Abdul El-Sayed’s path to victory and FDA approves first mRNA flu shot: Morning Rundown

A younger and higher-educated base were pivotal to Abdul El Sayed’s Senate Primary win, an analysis shows.

The U.S. Food and Drug Administration has approved Moderna’s flu vaccine for people aged 50 and older, the company said on Wednesday, marking the first approval of a messenger RNA-based vaccine for seasonal flu.

After refusing to even review it, the FDA has approved Moderna's mRNA seasonal flu vaccine.

The Food and Drug Administration approved Moderna's mRNA seasonal flu vaccine on Wednesday.

The U.S. Food and Drug Administration has approved a new seasonal flu vaccine from Moderna that uses mRNA technology, the drugmaker announced.

The shot, mFlusiva, was given a ​traditional approval for adults aged 50 to 64.

FDA Approves First mRNA Flu Vaccine in Win for Moderna After Arduous Process  WSJ

The agency had initially refused to even review the application but reversed course after a public outcry.

US FDA approves first mRNA flu shot from Moderna  Reuters

The FDA has approved Moderna’s influenza vaccine, the first licensed flu shot made using messenger RNA technology.

Canada is now the second country to authorize a Phase I clinical trial for a Bundibugyo virus vaccine candidate after the U.K., according to federal officials in a news release.